SEC Form 4 · accession 0001140361-16-058612
Achaogen, Inc. · AKAO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Ian Friedland
Officer — Chief Medical Officer
Period of report
Mar 17, 2016
Accepted (ET)
Mar 21, 2016 · 6:33 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001301501
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF2 | Mar 17, 2016 | S | 1,772 | $3.22 | D | 32,728 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The shares were sold solely to cover the tax liability of the Reporting Person on the vesting of Restricted Stock Units of the Issuer.
- F2Includes 24,750 Restricted Stock Units.